A Prospective Analysis of DAXX/ATRX Testing for Surgically Resected Pancreatic Neuroendocrine Tumors Reveals Loss of Expression for DAXX/ATRX is Associated with the Development of Metastatic Disease

被引：0
|
作者：
Bell, Phoenix [1 ]
Smith, Katelyn [1 ]
Singhi, Aatur [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1451
引用
收藏
页码：S1815 / S1816
页数：2
相关论文
共 50 条
  • [1] ATRX/DAXX Loss Is Highly Specific for Metastatic Pancreatic Neuroendocrine Tumors
    Heayn, Michelle
    Seethala, Raja R.
    Singhi, Aatur
    MODERN PATHOLOGY, 2016, 29 : 441A - 441A
  • [2] ATRX/DAXX Loss Is Highly Specific for Metastatic Pancreatic Neuroendocrine Tumors
    Heayn, Michelle
    Seethala, Raja R.
    Singhi, Aatur
    LABORATORY INVESTIGATION, 2016, 96 : 441A - 441A
  • [3] DAXX/ATRX loss and chromosomal instability in pancreatic neuroendocrine tumors (pNETs)
    Marinoni, I.
    Schmitt-Kurrer, A.
    Speel, E. J.
    Perren, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S152 - S152
  • [4] Study of clinicopathological features, hormone immunoexpression, and loss of ATRX and DAXX expression in pancreatic neuroendocrine tumors
    Yadav, Rajni
    Kakkar, Aanchal
    Sharma, Atul
    Malik, Prabhat Singh
    Sharma, Mehar Chand
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (08) : 994 - 999
  • [5] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
    Singhi, Aatur D.
    Liu, Ta-Chiang
    Roncaioli, Justin L.
    Cao, Dengfeng
    Zeh, Herbert J.
    Zureikat, Amer H.
    Tsung, Allan
    Marsh, J. Wallis
    Lee, Kenneth K.
    Hogg, Melissa E.
    Bahary, Nathan
    Brand, Randall E.
    McGrath, Kevin M.
    Slivka, Adam
    Cressman, Kristi L.
    Fuhrer, Kimberly
    O'Sullivan, Roderick J.
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 600 - 609
  • [6] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients With Pancreatic Neuroendocrine Tumors
    Singhi, A. D.
    Liu, T. -C.
    Roncaioli, J. L.
    Zeh, H. J.
    Zureikat, A. H.
    Tsung, A.
    Marsh, J. W.
    Lee, K. K.
    Hogg, M. E.
    Bahary, N.
    Brand, R. E.
    McGrath, K.
    Slivka, A.
    Cressman, K. L.
    Fuhrer, K.
    O'Sullivan, R. J.
    PANCREAS, 2016, 45 (10) : 1539 - 1539
  • [7] CHGA and DAXX/ATRX expression influence the outcome of pancreatic head neuroendocrine tumors
    Amin, T.
    Viol, F.
    Awwad, F.
    Frundt, T.
    Fraune, C.
    Clauditz, T. S.
    Sauter, G.
    Niessen, A.
    Izbicki, J.
    Hackert, T.
    Huber, S.
    Schrader, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 75 - 75
  • [8] Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
    Marinoni, Ilaria
    Kurrer, Anja Schmitt
    Vassella, Erik
    Dettmer, Matthias
    Rudolph, Thomas
    Banz, Vanessa
    Hunger, Fabio
    Pasquinelli, Silvan
    Speel, Ernst-Jan
    Perren, Aurel
    GASTROENTEROLOGY, 2014, 146 (02) : 453 - +
  • [9] Loss of Expression of DAXX and ATRX in Low-Grade Neuroendocrine Tumors (Carcinoid Tumors)
    Zhao, Q.
    Weng, S.
    Foo, W.
    Estrella, J. S.
    Yao, J. C.
    Wang, H.
    Wang, H.
    Rashid, A.
    MODERN PATHOLOGY, 2012, 25 : 187A - 187A
  • [10] Loss of Expression of DAXX and ATRX in Low-Grade Neuroendocrine Tumors (Carcinoid Tumors)
    Zhao, Q.
    Weng, S.
    Foo, W.
    Estrella, J. S.
    Yao, J. C.
    Wang, H.
    Wang, H.
    Rashid, A.
    LABORATORY INVESTIGATION, 2012, 92 : 187A - 187A
12345